This wiki has undergone a migration to Confluence found Here
Difference between revisions of "October Pharmacy WGM Agenda"
Jump to navigation
Jump to search
Smrobertson (talk | contribs) (update from 21 Sept teleconference) |
|||
(10 intermediate revisions by 2 users not shown) | |||
Line 57: | Line 57: | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3||[[Image:Technical_med.gif|24px]]||Joint meeting with O&O - O&O hosting | ||Q3||[[Image:Technical_med.gif|24px]]||Joint meeting with O&O - O&O hosting | ||
− | ||NA <br> Melva not available||NA||TBD | + | ||NA <br> Melva, Marla not available||NA||TBD |
|- | |- | ||
||Q4||[[Image:Technical_med.gif|24px]]|| Joint meeting with O&O - O&O hosting | ||Q4||[[Image:Technical_med.gif|24px]]|| Joint meeting with O&O - O&O hosting | ||
− | ||NA <br> Melva not available||NA||TBD | + | ||NA <br> Melva, Marla not available||NA||TBD |
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
Line 79: | Line 79: | ||
* Status of 2 outstanding ballots for publication | * Status of 2 outstanding ballots for publication | ||
* Review outstanding FHIR GForge tracker items | * Review outstanding FHIR GForge tracker items | ||
− | || | + | ||Scott||Melva||TBD |
|- | |- | ||
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting - Joint with FHIR<br> | ||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting - Joint with FHIR<br> | ||
Line 85: | Line 85: | ||
* Modeling resources needed | * Modeling resources needed | ||
* FHIR resources needed | * FHIR resources needed | ||
− | * Pharmacy examples | + | * Pharmacy examples - can these be included as part of 2.1? |
− | ||Melva | + | ||Scott||Melva|||TBD |
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* Prepare for meeting SDWG resources - Wed Q3 | * Prepare for meeting SDWG resources - Wed Q3 | ||
+ | ** Is there a clear way to identify brand vs generic since they are all send in the code element? Or is the general recommendation to not send brand-equivalent or generic-equivalent codes in medications? | ||
+ | **Approach for expressing drug classes | ||
+ | ** Quick review and update to matrix of medication scenarios and representation details | ||
+ | ** Discuss use of list resource and mapping to C-CDA (did this previously, but think it wouldn’t hurt to review again) | ||
* Pharmacy Glossary Project - Discussion | * Pharmacy Glossary Project - Discussion | ||
* Discussion of Pharmacy Webinar - Discussion | * Discussion of Pharmacy Webinar - Discussion | ||
* Action Item List | * Action Item List | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | ||Melva | + | ||Melva||Marla||TBD |
|- | |- | ||
||Q4||[[Image:Technical_med.gif|24px]]||Joint with PHER (PHER hosting) (John H will attend) <br> | ||Q4||[[Image:Technical_med.gif|24px]]||Joint with PHER (PHER hosting) (John H will attend) <br> | ||
Line 114: | Line 118: | ||
** 3 year plan review | ** 3 year plan review | ||
** Action Item list review | ** Action Item list review | ||
− | * Discussion of joint meeting with ISO and IHE | + | * Discussion of joint meeting with ISO and IHE - Michael Tan is joining |
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | || | + | ||Marla||Melva||TBD |
|- | |- | ||
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
− | * Pharmacy Template Work (Kai | + | * Pharmacy Template Work (Kai) |
− | + | ||Melva||John||TBD | |
− | || | ||
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
* Joint topics with SDWG | * Joint topics with SDWG | ||
− | ||Melva | + | * Is there a clear way to identify brand vs generic since they are all send in the code element? Or is the general recommendation to not send brand-equivalent or generic-equivalent codes in medications? |
+ | * Approach for expressing drug classes | ||
+ | * Quick review and update to matrix of medication scenarios and representation details | ||
+ | * Discuss use of list resource and mapping to C-CDA (did this previously, but think it wouldn’t hurt to review again) | ||
+ | ||Melva||Marla||TBD | ||
|- | |- | ||
− | ||Q4||[[Image:Technical_med.gif|24px]]|| | + | ||Q4||[[Image:Technical_med.gif|24px]]||Joint Meeting with Patient Care - Pt Care Hosting |
− | + | ||NA||NA||TBD | |
− | || | ||
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
|. ||||||||||||||||| | |. ||||||||||||||||| | ||
Line 140: | Line 146: | ||
||Q1||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q1||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | ||Marla|| | + | ** http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8691&start=0 |
+ | ** http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8690&start=0 | ||
+ | ** http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8689&start=0 | ||
+ | ** http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8688&start=0 | ||
+ | ||Marla||Scott||TBD | ||
|- | |- | ||
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | || | + | ||John||Marla||TBD |
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | ||Marla|| | + | ||Marla||John||TBD |
|- | |- | ||
||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | || | + | ||John||Marla||TBD |
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
|. ||||||||||||||||| | |. ||||||||||||||||| |
Latest revision as of 14:17, 6 October 2015
Contents |
Related Links |
Agenda
Day | Date | ' | Time | Icon | Event | Chair | Scribe | Room |
Sunday | October 4, 2015 | AM | Q1 | Pharmacy WG Not Meeting | NA | NA | NA | |
Q2 | Pharmacy WG Not Meeting | NA | NA | NA | ||||
PM | Q3 | Pharmacy WG Not Meeting | NA | NA | NA | |||
Q4 | Pharmacy WG Not Meeting | NA | NA | NA | ||||
. | ||||||||
Monday | October 5, 2015 | AM | Q1 | Pharmacy WG Not Meeting | NA | NA | NA | |
Q2 | Pharmacy WG Not Meeting | NA | NA | NA | ||||
PM | Q3 | Joint meeting with O&O - O&O hosting | NA Melva, Marla not available |
NA | TBD | |||
Q4 | Joint meeting with O&O - O&O hosting | NA Melva, Marla not available |
NA | TBD | ||||
. | ||||||||
Tuesday | October 6, 2015 | AM | Q1 | Committee Meeting
|
Scott | Melva | TBD | |
Q2 | Committee Meeting - Joint with FHIR
|
Scott | Melva | TBD | ||||
PM | Q3 | Committee Meeting
|
Melva | Marla | TBD | |||
Q4 | Joint with PHER (PHER hosting) (John H will attend)
|
NA | NA | TBD | ||||
. | ||||||||
Wednesday | October 7, 2015 | AM | Q1 | Committee Meeting
|
Marla | Melva | TBD | |
Q2 | Committee Meeting
|
Melva | John | TBD | ||||
PM | Q3 | Committee Meeting
|
Melva | Marla | TBD | |||
Q4 | Joint Meeting with Patient Care - Pt Care Hosting | NA | NA | TBD | ||||
. | ||||||||
Thursday | October 8, 2015 | AM | Q1 | Committee Meeting
|
Marla | Scott | TBD | |
Q2 | Committee Meeting
|
John | Marla | TBD | ||||
PM | Q3 | Committee Meeting
|
Marla | John | TBD | |||
Q4 | Committee Meeting
|
John | Marla | TBD | ||||
. | ||||||||
Friday | October 9, 2015 | AM | Q1 | Pharmacy WG Not Meeting | NA | NA | NA | |
Q2 | Pharmacy WG Not Meeting | NA | NA | NA | ||||
PM | Q3 | Pharmacy WG Not Meeting | NA | NA | NA | |||
Q4 | Pharmacy WG Not Meeting | NA | NA | NA | ||||
. |
Icons: